Met Life Investment Management, LLC Actinium Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.56 - $9.89 $9,407 - $14,182	1,434 Added 10.36%	15,276 $113,000
Q1 2024 May 14, 2024	BUY	$5.0 - $9.2 $69,210 - $127,346	13,842 New	13,842 $108,000
Q3 2023 May 09, 2024	BUY	$5.91 - $7.37 $81,806 - $102,015	13,842 New	13,842 $81,000
Q2 2023 Apr 29, 2024	BUY	$7.15 - $9.39 $98,970 - $129,976	13,842 New	13,842 $102,000
Q2 2023 Aug 10, 2023	BUY	$7.15 - $9.39 $98,970 - $129,976	13,842 New	13,842 $102,000

7.94M

59.6K

4.8K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $39M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.